R&D

We promise to open new horizons in the biomedical field..

Pipeline

Pipeline Overview

Active candidates, which are the basis of the pipeline under development in our company, play an excellent role in protecting the development, regeneration, and damage of nerve cells through the regulation of mitochondrial function. The properties and mechanism of action of the pipeline drugs are as follows

  • 1. Neurotrophic substance synthesized from astrocytes and supplied to neurons
  • 2. Activation of intracellular glutathione
  • 3. Mitochondrial function control
  • 4. Protection of cognitive and memory-related nerve cell damage
  • 5. Induction of regenerative phagocytic M2 type differentiation of microglia
  • Pipeline name
  • Indications
  • Substance derivation
  • Nonclinical
  • Clinical phase 1
  • Clinical phase 2
  • Clinical phase 3
  • Approval
AST-001 Autism spectrum disorder
임상 1상초기
AST-002 Traumatic brain injury, cerebrovascular disease
임상 1상초기
AST-009 Degenerative brain diseases such as Parkinson's disease
전임상 초기
AST-011 Alzheimer's disease
전임상 초기
AST-025 Cerebral infarction
물질도출 초기